期刊文献+

孟鲁司特钠对哮喘慢性持续期患儿IL-2、肿瘤坏死因子及肺功能的影响 被引量:6

Montelukast sodium is an asthmatic slow duration IL-2,the lung function and necrosis of factors influence
下载PDF
导出
摘要 目的观察孟鲁司特钠对哮喘慢性持续期患儿IL-2、肿瘤坏死因子及肺功能的影响。方法随机选择门诊处于哮喘慢性持续期的患儿52例,随机分为两组,治疗观察1年。观察治疗前后IL-2、肿瘤坏死因子及肺功能的变化。结果孟鲁司特钠组患儿血IL-2升高、肿瘤坏死因子含量降低,各项肺功能指标明显提高,治疗前后比较差异有统计学意义(P<0.05)。结论孟鲁司特钠能降低气道高反应性,增强免疫因子IL-2、降低致炎性肿瘤坏死因子含量,调节Th1/Th2平衡。 Objective: Montelukast sodium is an asthmatic slow duration IL-2,the factor of necrosis and lungs.Methods: random choice clinic is in chronic asthma duration of the 52 cases randomly divided into two groups.the treatment of observation.observation a year before and after treatment IL-2,the factor of necrosis and lungs.Results:Montelukast sodium group blood IL-2 increase,the tumor necrosis factor,lung function in various indicators improved obviously and treatment are differences and there are statistical significance(P 0.05).Conclusion:Montelukast sodium can reduce high response to the press,enhancement immunity factor IL-2、 the colors of the dead level of cytokine factor,adjust Th1/ Th2 balance.
作者 李维新 刘敏
出处 《泰山医学院学报》 CAS 2010年第5期364-367,共4页 Journal of Taishan Medical College
关键词 孟鲁司特钠 IL-2 肿瘤坏死因子 肺功能 慢性持续期患儿 Montelukast sodium IL-2 lung tumor necrosis factor the slow duration
  • 相关文献

参考文献8

  • 1谢燕清,张清玲,高怡,安嘉颖,陈桥丽,何桦,郑劲平.学龄前哮喘儿童常用吸入器阻力下吸气峰流量的研究[J].中国实用儿科杂志,2008,23(8):573-578. 被引量:2
  • 2儿童支气管哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10):745-753. 被引量:2514
  • 3WeissJW,DragenJM,MeFaddenER,etal.Airway constriction in normal humans produced by inhala of leukotrienes:potency,time course and effect of aspirin therapy[J].JAMA,1983,249:2814-2817.
  • 4CohenP,NoveralJP,Bhala A,etal.Leukotriened4 facilitates airway smooth muscle cell proliferation via modulation of the LGF axis[J].Am J physiol,1995,269(2ptl):L151-157.
  • 5Wood-BakerR,Town GI,Benning B,etal.The reproducibility and effect on non-specific airway responsiveness of inhaled prostaglan D2 and leukotriene D4 inasthmatic[J].Br Clin Phannacol,1995,39:119-123.
  • 6石筱蕾,王永清,顾燕明.孟鲁斯特治疗咳嗽变异性哮喘的疗效观察[J].江苏大学学报(医学版),2005,15(5):426-427. 被引量:7
  • 7Robertson CF,Price D,Henry R etal.Short-course montrlukast for intermittent asthma in children:a randomized controlled trial Am J Respir Crit Care Med,2007,175:323-329.
  • 8沈晓明,王卫平.儿科学[M].第七版.北京:人民卫生出版社,2008:267.

二级参考文献11

  • 1张清玲,郑劲平,袁本通,何桦,王健,安嘉颖,张敏,罗定芬,陈桂莲.深圳地区学龄前儿童用力肺活量测定的可行性及正常预计值公式[J].中华儿科杂志,2005,43(11):843-848. 被引量:18
  • 2张清玲,郑劲平,袁本通,何桦,王健,安嘉颖,张敏,罗定芬,陈桂莲.学龄前儿童用力肺活量测定的质量控制分析[J].中国实用儿科杂志,2006,21(4):259-264. 被引量:9
  • 3全国儿科哮喘协作组.儿童哮喘病诊断标准和治疗常规[J].中华儿科杂志,1998,36(12):747-750.
  • 4Todokoro M,Mochizuki H,Tokuyama K,et al. Childhood cough variant asthma and its relationship to classic asthma[J]. Ann Allergy Asthma Immunol,2003,90(6): 652-659.
  • 5康小会 刘艳霞 陈再历.布地奈德雾化吸入治疗儿童哮喘急性发作的疗效观察[J].哮喘杂志,2001,7(2):83-83.
  • 6Knorr B,Franchi JM,Bisgaard H,et al.Montelukast,a leukotriene receptor antagonist for the treatment of persistent asthma in childen aged 2 to 5 years [J].Pediatrics,2001,108(3):48.
  • 7Minoguchi K,Kohno Y,Minoguchi H,et al. Redution of cosinophilic inflammation in the airways of patients with asthma using montelukast[J].Chest,2002,121:732-738.
  • 8Spector SL,Tan RA. Effectiveness of montelukast in the treatment of cough variant asthma[J]. Ann Allergy Asthma Immunol,2004,93(3):232-236.
  • 9姚海华.咳嗽变异型哮喘的诊断与治疗[J].包头医学,2000,24(3):24-25. 被引量:1
  • 10中华医学会儿科学分会呼吸学组.儿童支气管哮喘防治常规(试行)[J].中华儿科杂志,2004,42(2):100-106. 被引量:2631

共引文献2571

同被引文献51

引证文献6

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部